title: Response by Resor and Mauri to Letter Regarding Article, "Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study".
authors.affiliation: From Division of Cardiology and Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, MA (C.D.R., L.M.); and Harvard Medical School, Boston, MA (L.M.).
authors.forename: Charles D
authors.initials: CD
authors.lastname: Resor
authors.affiliation: From Division of Cardiology and Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, MA (C.D.R., L.M.); and Harvard Medical School, Boston, MA (L.M.).
authors.forename: Laura
authors.initials: L
authors.lastname: Mauri
mesh_terms: D001241:Aspirin; D004359:Drug Therapy, Combination; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin